Benzinga | May 4, 2021 04:32PM EDT

Apollo Endosurgery Q1 EPS $(0.17) Beats $(0.22) Estimate, Sales $13.90M Beat $11.71M Estimate

Apollo Endosurgery (NASDAQ:APEN) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.22) by 22.73 percent. This is a 65.31 percent increase over losses of $(0.49) per share from the same period last year. The company reported quarterly sales of $13.90 million which beat the analyst consensus estimate of $11.71 million by 18.70 percent. This is a 29.69 percent increase over sales of $10.72 million the same period last year.